Research Topic · Peer-Reviewed

Biomarkers

Biomarkers are objectively measurable biological characteristics that indicate normal physiological processes, pathological states, or responses to therapeutic intervention. They may be molecular, cellular, or imaging-based, and include proteins, genes, microRNAs, metabolites, epigenetic modifications, and other ana…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 14× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Biomarkers are objectively measurable biological characteristics that indicate normal physiological processes, pathological states, or responses to therapeutic intervention. They may be molecular, cellular, or imaging-based, and include proteins, genes, microRNAs, metabolites, epigenetic modifications, and other analytes detectable in blood, tissue, or body fluids. In hematology and oncology, biomarkers underpin early detection, diagnosis, prognosis, prediction of treatment response, and disease monitoring, enabling stratification of patients and the rational application of targeted therapy. They are conventionally classified by function, encompassing diagnostic, prognostic, predictive, and pharmacodynamic markers, and their clinical utility depends on analytical validity, reproducibility, and clinical relevance. Molecular and epigenetic biomarkers, including microRNA expression signatures and DNA methylation patterns, have been investigated for the detection and characterization of malignancies such as head and neck cancer and hepatocellular carcinoma, while circulating and cellular markers extend to immunomonitoring of cancer and infectious disease. Discovery and validation increasingly integrate genomic, proteomic, and immunological platforms, and biomarkers also bridge into nutrition, inflammation, and developmental and reproductive contexts. The journal publishes peer-reviewed research on biomarker discovery, validation, and application, including molecular, microRNA, epigenetic, and immunological markers for the diagnosis, prognosis, and monitoring of cancer and related conditions across clinical and laboratory settings.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2018

Molecular Biomarkers: A Brief Review

Tarassishin LeonidCorresponding author
 Department of Biological Sciences.
Exact topic Proteomics and Genomics Research doi:10.14302/issn.2326-0793.jpgr-18-2418
2018

Epigenetic Biomarkers in Head and Neck Cancer 

Gupta ShilpiCorresponding author
Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida-201313, India.
Exact topic Cancer Genetics And Biomarkers Cited by 11 doi:10.14302/issn.2572-3030.jcgb-18-2428

How this research is being cited

The 12 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Biomarkers, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.